<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number 000-26326
------------------------------------------
Professional Veterinary Products, Ltd.
---------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
10100 J Street, Omaha, Nebraska 68127 (402) 331-4440
---------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock
---------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
---------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) /X/ Rule 12h-3(b)(1)(ii) / /
Rule 12g-4(a)(1)(ii) / / Rule 12h-3(b)(2)(i) / /
Rule 12g-4(a)(2)(i) / / Rule 12h-3(b)(2)(ii) / /
Rule 12g-4(a)(2)(ii) / / Rule 15d-6 / /
Rule 12h-3(b)(1)(i) / /
Approximate number of holders of record as of the certification or notice
date: None.*
*In accordance with SEC No-Action Letter granted July 12, 1996, to Registrant,
there are no shareholders of "securities" as defined under Section 12(g) of the
Securities Exchange Act of 1934.
Pursuant to the requirements of the Securities Exchange Act of 1934
Professional Veterinary Products, Ltd. has caused this certification/notice to
be signed on its behalf by the undersigned duly authorized person.
DATE September 23, 1996 BY: /s/ Dr. Lionel Reilly
------------------------------- -------------------------------------
Dr. Lionel Reilly, President
